|
Dr. Hariri is currently the President of the Cellular Therapeutics Division of Celgene Corporation. Dr. Hariri founded Anthrogenesis Corporation in 1997, which subsequently was acquired by Celgene in 2002. Dr. Hariri has since been responsible for leading the development of new human stem cell and tissue therapeutics at the Celgene Cellular Therapeutics Division. Prior to founding Anthrogenesis, Dr. Hariri held various faculty positions at the Cornell University Medical College and served as an advisor to many pharmaceutical and medical device enterprises. Dr. Hariri received his M.D. and Ph.D. degrees from Cornell University and his surgical training at the New York Hospital-Cornell Medical Center. | 